Comparison of the Effectiveness of Single Oral Antidiabetic Drugs with Combination Antidiabetic Drugs in Lowering Blood Sugar in Type 2 Diabetes Mellitus Patients at UKI General Hospital in 2014-2017
Abstract
Diabetes Mellitus is a disease characterized by hyperglycemia or the glucose in the blood increased or beyond ordinary. The national prevalence of Diabetes Mellitus in Indonesia is 6,9%. Patients with Diabetes Mellitus can be given antidiabetic drugs such as sulfonylurea and glinid. The antidiabetic drug can be consumed as a combination or single. This study aims to determine whether there is a significant efficacy comparison between antidiabetic combination therapy and single antidiabetic therapy. This study is a retrospective casual research by looking at the medical record. From 30 patients, 15 patients using oral antidiabetic combination therapy and 15 patients using oral antidiabetic single therapy, there were mean differences on the first day where patients using oral antidiabetic single therapy mean 228,47 and patients using oral antidiabetic combination therapy mean 294,07. There is no significant difference between single antidiabetic therapy or antidiabetic combination therapy from the statistic test.
Keywords: Diabetes, Antidiabetic effectiveness
Keywords:
Diabetes, Antidiabetic effectivenessDOI
https://doi.org/10.22270/jddt.v12i1-S.5219References
Qaribi, Mahanta, Dewi Elizadiani Suza, and Rosina Tarigan. "Effect Of Education In Preventing Diabetic Foot Ulcers To Compliance And Quality Of Life The Diabetic Patients." European Journal of Molecular & Clinical Medicine 2021; 8(3).
van de Laar, Floris Alexander. "Alpha-glucosidase inhibitors in the early treatment of type 2 diabetes." Vascular health and risk management 2008; 4(6):1189. https://doi.org/10.2147/VHRM.S3119
Trento, Marina, P. Passera, M. Bajardi, M. Tomalino, G. Grassi, E. Borgo, C. Donnola, Franco Cavallo, Piervincenzo Bondonio, and Massimo Porta. "Lifestyle intervention by group care prevents deterioration of Type II diabetes: a 4-year randomized controlled clinical trial." Diabetologia 2002; 45(9):1231-1239. https://doi.org/10.1007/s00125-002-0904-8
Ozougwu, J. C., K. C. Obimba, C. D. Belonwu, and C. B. Unakalamba. "The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus." Journal of physiology and pathophysiology 2013; 4(4):46-57. https://doi.org/10.5897/JPAP2013.0001
Xu, Yunzhi, and Guangjie Chen. "Mast cell and autoimmune diseases." Mediators of inflammation 2015 (2015). https://doi.org/10.1155/2015/246126
Höppener, Jo WM, and Cees JM Lips. "Role of islet amyloid in type 2 diabetes mellitus." The international journal of biochemistry & cell biology 2006; 38(5-6):726-736. https://doi.org/10.1016/j.biocel.2005.12.009
Jiang, Jingjing, Lin Zhao, Liu Lin, Minghui Gui, Qiqige Aleteng, Bingjie Wu, Shanshan Wang, Baishen Pan, Yan Ling, and Xin Gao. "Postprandial blood glucose outweighs fasting blood glucose and HbA1c in screening coronary heart disease." Scientific reports 2017; 7(1):1-7. https://doi.org/10.1038/s41598-017-14152-y
Wilson, D. C., D. Kalnins, C. Stewart, N. Hamilton, A. K. Hanna, P. R. Durie, E. Tullis, and P. B. Pencharz. "Challenges in the dietary treatment of cystic fibrosis related diabetes mellitus." Clinical Nutrition 2000; 19(2):87-93. https://doi.org/10.1054/clnu.1999.0081
Inzucchi, Silvio E., Richard M. Bergenstal, John B. Buse, Michaela Diamant, Ele Ferrannini, Michael Nauck, Anne L. Peters, Apostolos Tsapas, Richard Wender, and David R. Matthews. "Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)." Diabetes Spectrum 2012; 25(3):154-171. https://doi.org/10.2337/diaspect.25.3.154
Pfeiffer, Andreas FH. "Oral hypoglycemic agents: Sulfonylureas and meglitinides." In Type 2 Diabetes, pp. 111-120. CRC Press, 2016.
McLeod, James F. "Clinical pharmacokinetics of nateglinide." Clinical pharmacokinetics 2004; 43(2):97-120. https://doi.org/10.2165/00003088-200443020-00003
Lewis, ALAN B., MICHAEL D. Freed, MICHAEL A. Heymann, SHARON L. Roehl, and ROSEMARY CHEN Kensey. "Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease." Circulation 64, no. 5 (1981): 893-898. https://doi.org/10.1161/01.CIR.64.5.893
Nichols, Gregory A., Charles M. Alexander, Cynthia J. Girman, Sachin J. Kamal-Bahl, and Jonathan B. Brown. "Treatment escalation and rise in HbA1c following successful initial metformin therapy." Diabetes Care 2006; 29(3):504-509. https://doi.org/10.2337/diacare.29.03.06.dc05-1937
Chang, Kai Lun, Hai Ning Pee, Shili Yang, and Paul C. Ho. "Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease." Scientific reports 2015; 5(1):1-7. https://doi.org/10.1038/srep09000
Dubé, Philip E., Catherine L. Forse, Jasmine Bahrami, and Patricia L. Brubaker. "The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice." Gastroenterology 2006; 131(2):589-605. https://doi.org/10.1053/j.gastro.2006.05.055
Anbarasan, V. "Comparison on Efficacy and Safety of Linagliptin Vs. Sitagliptin Among Type 2 Diabetic Patients." PhD diss., Ultra College of Pharmacy, Madurai, 2014.
Rosenthal, Norm, Gary Meininger, Kirk Ways, David Polidori, Mehul Desai, Rong Qiu, Maria Alba et al. "Canagliflozin: a sodium glucose co‐transporter 2 inhibitor for the treatment of type 2 diabetes mellitus." Annals of the New York Academy of Sciences 2015; 1358(1):28-43. https://doi.org/10.1111/nyas.12852
Tripathi, Brajendra Kumar, and Arvind Kumar Srivastava. "Diabetes mellitus: complications and therapeutics." Medical science monitor 2006; 12(7):RA130-RA147.
Lehne, Richard A., Linda A. Moore, Leanna J. Crosby, and Diane Bronkema Hamilton. Pharmacology for nursing care. Saunders/Elsevier, 2010.
Chaudhury, Arun, Chitharanjan Duvoor, Vijaya Sena Reddy Dendi, Shashank Kraleti, Aditya Chada, Rahul Ravilla, Asween Marco et al. "Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management." Frontiers in endocrinology 2017; 8:6. https://doi.org/10.3389/fendo.2017.00006
Chou, Ting-Chao. "Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies." Pharmacological reviews 2006; 58(3) 621-681 https://doi.org/10.1124/pr.58.3.10
Published
Abstract Display: 549 
PDF Downloads: 640 PDF Downloads: 57 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.